Full text is available at the source.
Abstract
Colorectal cancer (CRC) shows significant differences in clinical outcomes, indicating a need for reliable prognostic biomarkers.
- Aberrant expression of genes related to circadian rhythms may be linked to cancer development.
- The comprehensive role of these genes in CRC progression is not fully understood.
- Identifying prognostic biomarkers could help predict therapeutic vulnerabilities in CRC.
Simplified